AI assistant
IDEAYA Biosciences, Inc. — Director's Dealing 2021
Sep 8, 2021
31547_dirs_2021-09-07_ee2e269d-4df3-463c-b1ae-dfaae98be037.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEAYA Biosciences, Inc. (IDYA)
CIK: 0001676725
Period of Report: 2021-09-02
Reporting Person: Dillon Michael P. (SVP, Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Common Stock | S | 10000 | $25.0943 | Disposed | 78789 | Direct |
Footnotes
F1: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades in prices ranging from $24.95 to $25.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.